Overview
Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer
Status:
Unknown status
Unknown status
Trial end date:
2020-09-01
2020-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Post operative adjuvant chemotherapy followed by adjuvant Tamoxifen vs nil for patients with operable breast cancerPhase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
King Faisal Specialist Hospital & Research CenterTreatments:
Tamoxifen
Criteria
Inclusion Criteria:- Patients with operable breast cancer